AI Summary Scores: Intraday / Swing / Long scores are synthesized from multi-factor analysis for each timeframe. They summarize current conditions discussed in the report and do not constitute trading recommendations.
Intraday Trend Score: A 0–100 composite from the Trend Explorer™ analytics engine used for ranking and comparison. It describes current conditions and is not a forecast.
Trend Status: A rules-based label (Bullish / Mixed / Bearish) derived from signal confluence (trend structure, momentum, and positioning). It indicates alignment, not expected return.
Last
$66.04
+$1.70 (+2.65%) 12:19 PM ET
Prev closePrevC$64.34
OpenOpen$64.66
Day highHigh$66.45
Day lowLow$64.64
VolumeVol1,203,123
Avg volAvgVol4,698,241
On chart
Interval
Intervals apply to 1D & 5D.
Intervals apply to 1D & 5D.
Scale: Linear
Overlays
Panels
Style
Scale: Linear
Presets
Tools
Tickers only (no ^ indexes). Add up to 5.
Mkt cap
$31.78B
EV/Sales
0.12
P/E ratio
-6.40
FY Revenue
$204.60B
EPS
-10.32
Gross Margin
21.93%
Div yield
0.06%
Sector
Healthcare
AI report sections
MIXED
CNC
Centene Corporation
Centene’s share price is in the upper end of its 52-week range with very strong recent price momentum and multiple bullish technical signals, but momentum indicators are stretched into overbought territory. Fundamentally, the company combines large-scale revenue, improving cash generation, and a solid liquidity profile with negative earnings, pressured margins, and weak return metrics. Valuation appears low on sales and cash-flow multiples relative to the scale of the business, while short interest and recent news flow indicate only moderate skepticism and generally constructive sentiment.
AI summarized at 2:25 PM ET, 2026-06-09
AI summary scores
INTRADAY:63SWING:77LONG:48
Volume vs average
Intraday (cumulative)
+28% (Above avg)
Vol/Avg: 1.28×
RSI
47.32(Neutral)
Neutral (40–60)
0255075100
MACD momentum
Intraday
-0.02 (Weak)
MACD: 0.04 Signal: 0.06
Short-Term
-0.09 (Weak)
MACD: -0.02 Signal: 0.07
Long-Term
-0.10 (Weak)
MACD: 0.24 Signal: 0.34
Intraday trend score
72.67
LOW62.67HIGH73.67
Latest news
CNC•12 articles•Positive: 4Neutral: 3Negative: 5
PositiveZacks Investment Research• Na
Best Growth Stocks to Buy for August 31st
Zacks highlights three stocks with Rank #1 buy ratings and strong growth potential: Centene Corporation (managed care), Valero Energy Corporation (energy), and monday.com Ltd. (software). All three have seen significant increases in consensus earnings estimates over the last 60 days and possess favorable PEG ratios compared to their respective industries.
CNCVLOMNDYZacks Rank #1buy ratingsgrowth stocksearnings estimatesPEG ratio
Sentiment note
Zacks Rank #1 rating, 40.9% increase in consensus earnings estimate over 60 days, favorable PEG ratio of 0.35 vs. industry 1.28, and Growth Score of B indicate strong buy potential.
PositiveZacks Investment Research• Na
5 Defensive Stocks to Buy as Consumer Confidence Hits 7-Month Low
With consumer confidence hitting its lowest level since January due to inflation concerns and labor market uncertainty, five defensive stocks from consumer staples, healthcare, and utilities sectors are recommended: COCO, DAR, CNC, EXC, and AMRX. These stocks offer upside potential with strong earnings growth estimates and improved analyst consensus over the past 60 days.
Expected earnings growth exceeding 100% for current year, Zacks Consensus Estimate improved 40.9% over 60 days, Zacks Rank #1 (Strong Buy)
NegativeBenzinga• Vandana Singh
Membership Slump Forces Health Giant Centene Into Staff Buyouts: Report
Centene Corporation is launching a voluntary separation program to reduce workforce costs amid significant membership declines. The health insurer experienced a 2 million member drop in its ACA marketplace business following the expiration of pandemic-era federal subsidies. Total membership fell from 27.9 million to 26.27 million year-over-year, with marketplace membership declining from 5.626 million to 3.582 million in Q1. CEO Sarah London indicated the company prioritized margin over membership growth.
Centene faces significant headwinds including a 2 million member loss in ACA plans, total membership decline of 1.63 million year-over-year, and the need for workforce reductions through voluntary buyouts. The company's stock declined 2.08% on the news, reflecting investor concern about declining revenues and profitability challenges.
PositiveBenzinga• Nabaparna Bhattacharya
Nokia, Intel, And Sandisk Are Among Top 10 Large-Cap Gainers Last Week (April 27-May 1): Are the Others in Your Portfolio?
Ten large-cap stocks delivered strong performance during the week of April 27-May 1, driven by earnings beats and strategic announcements. Notable gainers include Atlassian (28.76%), Centene (25.68%), Twilio (27.36%), and Nokia (24.3%), with gains fueled by better-than-expected quarterly results, raised guidance, and analyst upgrades. Other top performers include Aurora Innovation, Bloom Energy, Seagate, NXP Semiconductors, Intel, and Sandisk.
Stock gained 25.68% after reporting better-than-expected Q1 results with multiple analyst price forecast increases
NeutralBenzinga• Vandana Singh
UnitedHealth, Humana, CVS Jump As CMS Boosts Medicare Payments
The Centers for Medicare & Medicaid Services announced a 2.48% increase in 2027 Medicare Advantage capitation rates, exceeding initial expectations of 0.09%. The boost amounts to over $13 billion in additional payments and reflects a 4.98% increase when accounting for risk score trends. CMS retained the 2024 risk adjustment model, providing greater rate predictability for insurers. Major healthcare stocks surged on the positive announcement.
UNHHUMCVSELVMedicare AdvantageCMS payment rates2027 capitation ratesrisk adjustment model
Sentiment note
Stock edged up only 0.48%, suggesting minimal market reaction despite the positive Medicare Advantage payment news
NegativeBenzinga• Nabaparna Bhattacharya
Centene, Paramount Skydance, And Ulta Beauty Are Among Top 10 Large Cap Losers Last Week (March 9-March 13): Are the Others in Your Portfolio?
Ten large-cap stocks experienced significant declines during the week of March 9-13, 2026. Fair Isaac Corporation led losses with a 21.59% drop following a $1 billion senior notes offering announcement. Other major decliners included Centene (20.85%), Ulta Beauty (16.04%), Paramount Skydance (15.4%), and Thomson Reuters (13.97%). Declines were attributed to factors including disappointing earnings guidance, analyst downgrades, and broader market pressures across healthcare, beauty, media, and aviation sectors.
U.S. stocks rallied Tuesday as crude oil plummeted 10% to $85/barrel following President Trump's signals that the Iran conflict may be ending soon and his commitment to keep the Strait of Hormuz safe. The S&P 500 rose 0.3%, Dow gained 0.4%, and Nasdaq 100 advanced 0.5%, while the VIX dropped 9.3% signaling reduced market fear.
Healthcare Transportation Service Report 2026-2035: A $155.25+ Billion Market by 2030 with Centene, Molina Healthcare, DHL, ARAMARK, Lyft Healthcare, and ModivCare Leading
The healthcare transportation service market is expected to grow from $116.47 billion in 2026 to $155.26 billion by 2030, with a CAGR of 7.5%. Growth drivers include aging populations, chronic disease prevalence, home healthcare expansion, and AI-powered route optimization. Leading companies include Centene, Molina Healthcare, DHL, ARAMARK, Lyft Healthcare, and ModivCare, with North America currently dominant and Asia-Pacific showing fastest growth.
CNCMOHARMKhealthcare transportationmedical transportpatient transportnon-emergency medical transportationAI-powered route optimization
Sentiment note
Listed as a leading company in the growing healthcare transportation service market, positioned to benefit from projected 7.5% CAGR growth through 2030.
NegativeBenzinga• Vandana Singh
Centene Takes A Hit As Medicaid Membership Shrinks
Centene Corporation reported mixed fourth-quarter 2025 results with revenue beating expectations at $49.73 billion, but the stock fell 5.87% due to a weak 2026 outlook. The company faced challenges from declining Medicaid membership (down to 12.52 million from 13.00 million) and a higher health benefits ratio of 94.3%, though it expects adjusted EPS above $3.00 for 2026.
Stock declined 5.87% despite beating revenue expectations. The decline was driven by shrinking Medicaid membership, elevated health benefits ratio (94.3%, up from 89.6%), and lower 2026 sales guidance ($186.5B-$190.5B vs. consensus $193.43B), indicating operational challenges and margin pressures despite positive EPS guidance.
NeutralInvesting.com• Timothy Fries
Philip Morris Beats Estimates as Smoke-Free Products Drive Earnings Momentum
Philip Morris International significantly exceeded earnings expectations with EPS of $7.54 vs. $1.70 expected and revenue of $10.4B vs. $10.39B expected, driven by strong growth in smoke-free products. Biogen also beat estimates with EPS of $1.99 vs. $1.61 expected, boosted by strong sales of LEQEMBI and SKYCLARYS. Centene reported mixed results but beat both EPS and revenue expectations. All three companies provided positive 2026 guidance.
Reported mixed results with EPS beat (-$1.19 vs -$1.22 expected) and revenue beat ($49.73B vs $48.39B expected), but faced a challenging year. However, strategic initiatives showing positive results with 2026 guidance of adjusted diluted EPS greater than $3.00.
NegativeBenzinga• Vandana Singh
Medicare Shock Sends UnitedHealth, Humana And CVS Tumbling
The Centers for Medicare & Medicaid Services (CMS) proposed a 2027 Medicare Advantage payment increase of only 0.09%, significantly below Wall Street's expectations of 4-6%. This modest growth announcement triggered sharp declines in major health insurer stocks, with UnitedHealth, Humana, and CVS Health leading the losses. The CMS emphasized program sustainability and payment accuracy through updated risk adjustment models.
Stock declined 7.26% as the lower-than-expected payment increase affects Medicaid and Medicare Advantage revenue streams.
NeutralBenzinga• Chandrima Sanyal
From Nio To Baidu: Themes Supercharges Trading With 7 New 2X Single-Stock ETFs
Leverage Shares by Themes launched seven new 2X leveraged single-stock ETFs on December 18, 2025, offering 200% daily performance exposure to stocks including Nio, Snap, Baidu, Centene, KLA, Petrobras, and Vale. These products carry a 0.75% expense ratio and are designed for short-term traders rather than long-term investors. The expansion brings Leverage Shares' total single-stock daily leveraged ETF offerings to 60.
Centene is included in the new ETF launch as an underlying asset with no company-specific news or developments mentioned.
News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks App
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal